Jazz Pharmaceuticals JAZZ Insider Ownership

NASDAQ JAZZ

$213.76 +5.33 (+2.56%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

2.21Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

3.34%

▼-0.082% pp QoQ

Shares Held by Insiders

2.17Mn

filed for Sep 2026

▼-2.40% QoQ

Shares Outstanding

64.91Mn

64,914,577 shares

Direct Holdings

2.06Mn

Indirect: 106.07K

Net Shares Traded (QoQ)

-53.33K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past 12 months, Jazz Pharmaceuticals insiders sold $69.82 million of stock on the open market (337.12K shares) and made no open-market purchases.

By number of insiders, Jazz Pharmaceuticals saw 11 insiders sell on the open market over the past 12 months and none buy.
The largest open-market sales of JAZZ in the past 12 months were by Bruce C. Cozadd (Director), totaling $27.78 million (143.5K shares), most recently on October 1, 2026.
Renee D. Gala (President & CEO) made the most recent open-market trade by an insider of Jazz Pharmaceuticals, a sale of 2K shares for $472,800 on October 6, 2026.
Beyond open-market trades, insiders at Jazz Pharmaceuticals received 188.65K shares in stock awards, acquired 216.32K shares through option exercises and conversions, gave up 99.55K shares to cover taxes or exercise prices and gave away 600 shares as gifts in the last 12 months.
Business Quant data shows Jazz Pharmaceuticals insiders holding 2.16Mn shares in total in their latest Form 4 filings, down 2.76% from 2.22Mn shares at the end of Q2 2026 and down 2.06% from 2.2Mn shares at the end of Q3 2025.
Of the 2.16Mn shares held by Jazz Pharmaceuticals insiders, 2.05Mn shares (95.09%) are held directly and 106.07K shares (4.91%) indirectly, through trusts, partnerships, family members and other entities.
Holdings in Jazz Pharmaceuticals stock are reported by 20 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Jazz Pharmaceuticals' top three insider holders by shares held are Seamus Mulligan (Director, 1.29Mn shares), Bruce C. Cozadd (Director, 345.88K shares) and Renee D. Gala (President & CEO, 141.39K shares).
Of the shares held by JAZZ insiders, 59.57% belong to Seamus Mulligan.
Institutional investors owned 99.06% of JAZZ shares as of Q2 2026, per their 13F filings.
In the past year, 19 insiders of Jazz Pharmaceuticals submitted 83 Form 4 filings reporting trades, awards or other transactions.
Insider figures for JAZZ include Form 4 filings through October 7, 2026.

Form 4 Holdings

Insiders Holding JAZZ

Insiders 26

Shares held 2.21Mn

Of outstanding 3.40%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Seamus Mulligan	Director	1,184,633	1,184,633	53.7%	07 Aug, 2026
2	Bruce C Cozadd	Chairman Ceo	345,875	345,875	15.7%	05 Oct, 2026
3	Renee D Gala	President Ceo	141,394	141,394	6.4%	07 Oct, 2026
4	Robert Iannone	Evp, Global Head Of Rd Cmo	65,686	65,686	3.0%	31 Aug, 2026
5	Philip L Johnson	Evp Chief Financial Officer	56,431	56,431	2.6%	02 Jul, 2026
6	Daniel N Jr Swisher	President And Coo	55,014	55,014	2.5%	07 Mar, 2023
7	Neena M Patil	Evp Chief Legal Officer	47,671	47,671	2.2%	14 Sep, 2026
8	Samantha Pearce	Evp, Chief Commercial Officer	47,131	47,131	2.1%	07 Aug, 2026
9	Kim Sablich	Evp, Gm Of U.S.	28,478	28,478	1.3%	07 Jun, 2023
10	Kenneth W O'Keefe	Director	25,811	25,811	1.2%	04 Dec, 2025
11	Mary Elizabeth Henderson	Svp, Technical Operations	23,815	23,815	1.1%	10 Sep, 2026
12	Finbar Larkin	Svp, Technical Operations	21,779	21,779	1.0%	07 Mar, 2023
13	Patrick G Enright	Director	21,278	21,278	1.0%	02 Sep, 2026
14	Heather Ann Mcsharry	Director	18,199	18,199	0.8%	02 Sep, 2026
15	Anne Oriordan	Director	16,500	16,500	0.7%	11 Aug, 2025
16	Peter Gray	Director	16,068	16,068	0.7%	15 Aug, 2023
17	Catherine A. Sohn	Director	14,868	14,868	0.7%	15 Aug, 2023
18	Christopher J. Tovey	Evp, Coo Managing Director E	14,663	14,663	0.7%	07 Jul, 2022
19	Jennifer E. Cook	Director	10,736	10,736	0.5%	02 Sep, 2026
20	Mark Douglas Smith	Director	9,579	9,579	0.4%	02 Sep, 2026
21	Rick E Winningham	Director	9,466	9,466	0.4%	02 Sep, 2026
22	Patrick Kennedy	Director	7,875	7,875	0.4%	02 Sep, 2026
23	Norbert G Riedel	Director	6,923	6,923	0.3%	02 Sep, 2026
24	Laura Hamill	Director	6,832	6,832	0.3%	02 Sep, 2026
25	Patricia Carr	Svp, Chief Accounting Officer	6,512	6,512	0.3%	09 Mar, 2026
26	Ted W Love	Director	2,389	2,389	0.1%	02 Sep, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

2,693 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
06 Oct, 2026	Renee D Gala	President Ceo	Disposed S	2,000	$236.40	$472.80K	141,394	Direct
01 Oct, 2026	Bruce C Cozadd	Director	Disposed S	6,000	$230.33	$1.38Mn	345,875	Direct
10 Sep, 2026	Neena M Patil	Evp Chief Legal Officer	Disposed S	1,200	$240.94	$289.13K	47,671	Direct
08 Sep, 2026	Mary Elizabeth Henderson	Svp, Technical Operations	Disposed F	1,412	$243.03	$343.16K	23,830	Direct
08 Sep, 2026	Renee D Gala	President Ceo	Disposed F	1,967	$246.81	$485.48K	145,394	Direct
08 Sep, 2026	Mary Elizabeth Henderson	Svp, Technical Operations	Disposed F	15	$241.20	$3.62K	23,815	Direct
08 Sep, 2026	Renee D Gala	President Ceo	Disposed S	2,000	$243.03	$486.06K	143,394	Direct
31 Aug, 2026	Laura Hamill	Director	Disposed F	14	$244.06	$3.42K	8,524	Direct
31 Aug, 2026	Bruce C Cozadd	Director	Disposed F	10	$244.06	$2.44K	359,084	Direct
31 Aug, 2026	Ted W Love	Director	Disposed F	6	$244.06	$1.46K	3,126	Direct
31 Aug, 2026	Jennifer E. Cook	Director	Disposed F	14	$244.06	$3.42K	12,428	Direct
31 Aug, 2026	Norbert G Riedel	Director	Disposed F	14	$244.64	$3.43K	8,615	Direct
31 Aug, 2026	Patrick Kennedy	Director	Disposed F	15	$244.06	$3.66K	8,292	Direct
31 Aug, 2026	Mary Elizabeth Henderson	Svp, Technical Operations	Disposed F	2,076	$241.39	$501.13K	25,258	Direct
31 Aug, 2026	Patrick G Enright	Director	Disposed F	14	$244.64	$3.43K	22,970	Direct
31 Aug, 2026	Rick E Winningham	Director	Disposed F	1,692	$241.39	$408.43K	9,480	Direct
31 Aug, 2026	Heather Ann Mcsharry	Director	Disposed F	15	$244.64	$3.67K	20,039	Direct
31 Aug, 2026	Mark Douglas Smith	Director	Disposed F	14	$244.64	$3.43K	11,271	Direct
31 Aug, 2026	Mary Elizabeth Henderson	Svp, Technical Operations	Disposed F	16	$244.64	$3.91K	25,242	Direct
31 Aug, 2026	Bruce C Cozadd	Director	Disposed F	1,209	$241.39	$291.84K	357,875	Direct

Showing 1 to 20 of 2,693 transactions